GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cara Therapeutics Inc (LTS:0HTC) » Definitions » E10

Cara Therapeutics (LTS:0HTC) E10 : $-1.98 (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cara Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cara Therapeutics's adjusted earnings per share data for the three months ended in Sep. 2024 was $-0.230. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.98 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-12-13), Cara Therapeutics's current stock price is $0.2647. Cara Therapeutics's E10 for the quarter that ended in Sep. 2024 was $-1.98. Cara Therapeutics's Shiller PE Ratio of today is .


Cara Therapeutics E10 Historical Data

The historical data trend for Cara Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cara Therapeutics E10 Chart

Cara Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -1.71 -1.82

Cara Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.81 -1.82 -1.90 -2.17 -1.98

Competitive Comparison of Cara Therapeutics's E10

For the Biotechnology subindustry, Cara Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cara Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cara Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cara Therapeutics's Shiller PE Ratio falls into.



Cara Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cara Therapeutics's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.23/133.0289*133.0289
=-0.230

Current CPI (Sep. 2024) = 133.0289.

Cara Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201412 -0.180 99.070 -0.242
201503 -0.210 99.621 -0.280
201506 -0.250 100.684 -0.330
201509 -0.190 100.392 -0.252
201512 -0.350 99.792 -0.467
201603 -0.390 100.470 -0.516
201606 -0.480 101.688 -0.628
201609 -0.420 101.861 -0.549
201612 -0.810 101.863 -1.058
201703 -0.810 102.862 -1.048
201706 -0.290 103.349 -0.373
201709 -0.380 104.136 -0.485
201712 -0.430 104.011 -0.550
201803 -0.510 105.290 -0.644
201806 -0.520 106.317 -0.651
201809 -0.510 106.507 -0.637
201812 -0.520 105.998 -0.653
201903 -0.560 107.251 -0.695
201906 -0.580 108.070 -0.714
201909 -0.740 108.329 -0.909
201912 -0.610 108.420 -0.748
202003 -0.620 108.902 -0.757
202006 -0.540 108.767 -0.660
202009 -0.350 109.815 -0.424
202012 1.690 109.897 2.046
202103 -0.470 111.754 -0.559
202106 -0.610 114.631 -0.708
202109 -0.020 115.734 -0.023
202112 -0.630 117.630 -0.712
202203 -0.520 121.301 -0.570
202206 -0.080 125.017 -0.085
202209 -0.430 125.227 -0.457
202212 -0.560 125.222 -0.595
202303 -0.490 127.348 -0.512
202306 -0.580 128.729 -0.599
202309 -0.520 129.860 -0.533
202312 -0.590 129.419 -0.606
202403 -0.560 131.776 -0.565
202406 -0.370 132.554 -0.371
202409 -0.230 133.029 -0.230

Add all the adjusted EPS together and divide 10 will get our e10.


Cara Therapeutics  (LTS:0HTC) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cara Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Cara Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Cara Therapeutics Business Description

Traded in Other Exchanges
Address
400 Atlantic Street, Suite 500, Stamford, CT, USA, 06901
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Cara Therapeutics Headlines

No Headlines